• Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) Receives Consensus Rating of "Moderate Buy" from Analysts

    Source: Buzz FX / 28 Feb 2025 03:11:19   America/New_York


    Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) Receives Consensus Rating of "Moderate Buy" from Analysts Written by MarketBeat February 28, 2025 Share Link copied to clipboard. Shares of Ultragenyx Pharmaceutical Inc.
    Read more...
Share on,